Company: IPSC
Filing Date: 2025-07-10
Form Type: S-3
Source: 0001104659-25-067022
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-07-10
Form: S-3
Chunk 0
---
TABLE OF CONTENTS

As filed with the Securities and Exchange Commission on July 10, 2025 Registration No. 333- UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 Century Therapeutics, Inc. (Exact name of Registrant as specified in its charter)

| ​ | Delaware                                                       
 (State or other jurisdiction ofincorporation or organization)​ | ​ | ​ | ​                                                                              | ​ | ​ | 84-2040295                          
 (I.R.S. EmployerIdentification No.) | ​ |
| ​ | ​                                                              | ​ | ​ | 25 North 38th Street, 11th FloorPhiladelphia, Pennsylvania 19104(267) 817-5790 | ​ | ​ |                                     |   |

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) Brent Pfeiffenberger, Pharm.D.
President and Chief Executive Officer
Century Therapeutics, Inc.
25 North 38th Street, 11th Floor
Philadelphia, Pennsylvania 19104
(267) 817-5790 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Rachael M. Bushey, Esq.
Jennifer L. Porter, Esq.
Justin Platt, Esq.
Goodwin Procter LLP
3025 John F Kennedy Blvd
Philadelphia, PA 19104
(445) 207-7800 Approximate date of commencement of proposed sale to the public : From time to time after the effective date of this Registration Statement. If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐ If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under